66 Y (Lamivudine 150 mg)
Pill imprint 66 Y has been identified as Lamivudine 150 mg.
Lamivudine is used in the treatment of hepatitis b; occupational exposure; hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 66 Y (Lamivudine 150 mg)
- 150 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Aurobindo Pharma USA, Inc.
Lamivudine is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...